Anormalidades hematológicas en pacientes con el SARS-CoV-2 (COVID-19) y sus implicaciones pronósticas

Castellanos-Sinco, Humberto B.; Pellón-Téllez, Karen; Rodríguez-Fuentes, Katherine; Mendoza-Oliva, Marino; Baltodano-Martínez, Yubelka; Muñoz-Vega, Juan; Tapia-Bravo, Mario; Tellería-Arispe, Claudia; Mora-Estrada, Manuel de la; Ramos-Peñafiel, Christian; Zazueta-Pozos, Francisco; Barranco-Lampón, Gilberto; Montaño-Figueroa, Efreen; Martínez-Murillo, Carlos.
Gac. méd. Méx ; 157(supl.3): S16-S22, feb. 2021. tab
Artículo en Español | LILACS-Express | ID: biblio-1375497

Documentos relacionados

  1. Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities.
  2. Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants.
  3. Hematological Profile with Peripheral Blood Smear Morphology of Admitted COVID-19 Infected Patients: A Study at a COVID Dedicated Hospital in Kashmir.
  4. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
  5. Evolutionary Insight into Immunothrombosis as a Healing Mechanism.
  6. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
  7. Pathophysiology of coronavirus-19 disease acute lung injury.
  8. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
  9. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease.
  10. Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.